Novavax director receives RSU and option awards
Novavax director Rachel K. King reported equity compensation activity and no share sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Novavax director Rachel K. King reported equity compensation activity and no share sales. On June 20, 2026 she exercised 18,880 restricted stock units (RSUs), receiving 18,880 shares of common stock, bringing her direct common stock holdings to 44,070 shares.
On June 18, 2026 she received two new awards under Novavax’s Amended and Restated 2015 Stock Incentive Plan: 14,180 RSUs and a stock option for 21,270 shares of common stock at an exercise price of $9.13 per share. The footnotes state that 100% of the new RSUs and option shares will vest on the first anniversary of the June 18, 2026 grant date, subject to her continued service on the board.
Insider Trade Summary
18,880 shares exercised/converted
Exercise
4 txns
Insider
King Rachel K.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 18,880 | $0.00 | $0.00 |
| Exercise | Common Stock | 18,880 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 21,270 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 14,180 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,270 contracts (Direct);
Restricted Stock Units — 14,180 contracts (Direct);
Common Stock — 44,070 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- F2. One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
- F3. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
- F4. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date
Key Figures
RSUs exercised: 18,880 shares
Common shares held: 44,070 shares
New RSU grant: 14,180 units
+3 more
6 metrics
RSUs exercised
18,880 shares
RSUs converted into common stock on June 20, 2026
Common shares held
44,070 shares
Direct common stock holdings after June 20, 2026
New RSU grant
14,180 units
RSUs granted on June 18, 2026
New option grant
21,270 shares
Stock option covering common stock granted June 18, 2026
Option exercise price
$9.13 per share
Conversion or exercise price for new stock option
Derivative exercises
18,880 shares
Exercise or conversion of derivative securities per transaction summary
Key Terms
Restricted Stock Units, Amended and Restated 2015 Stock Incentive Plan, stock option, vest, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2015 Stock Incentive Plan financial
"shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest"
stock option financial
"shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"One hundred percent (100%) of the RSUs subject to this grant ... will vest on the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Novavax (NVAX) director Rachel K. King report?
Rachel K. King reported only equity acquisitions. She exercised 18,880 RSUs into common shares and received new grants of 14,180 RSUs and a stock option for 21,270 shares as board compensation, with no reported share sales.
What new equity awards did Novavax (NVAX) grant to Rachel K. King?
Novavax granted Rachel K. King 14,180 restricted stock units and a stock option covering 21,270 shares of common stock at a $9.13 exercise price. Both awards were made under the Amended and Restated 2015 Stock Incentive Plan as amended.
When do Rachel K. King’s new Novavax (NVAX) RSUs and options vest?
The filing states that 100% of the RSUs and 100% of the stock option shares granted on June 18, 2026 will vest on the first anniversary of that grant date, provided she continues serving on Novavax’s board of directors through the vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
